PCN124 BUDGET IMPACT ANALYSIS OF IMMUNOTHERAPY AS SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AT MEXICO´S NATIONAL INSTITUTE OF CANCER
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.320
https://www.valueinhealthjournal.com/article/S1098-3015(19)32698-1/fulltext
Section Title :
Section Order :
10259
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32698-1&doi=10.1016/j.jval.2019.09.320